Tender Summary: Cystofix Suprapubic Kit Size 16

Objectives

The Department of Health, KwaZulu-Natal, aims to procure essential medical supplies for Harry Gwala Regional Hospital. The primary objective is to secure a reliable source of sterile suprapubic catheter kits to support clinical procedures requiring bladder drainage where urethral access is contraindicated or impossible.

Scope of Supply

• Item Description: Cystofix suprapubic kit size 16.
• Quantity: 100 units.
• Contract Type: Once-off supply.
• Delivery Destination: Harry Gwala Regional Hospital.
• Price Validity: Quotations must remain firm for 90 days from the closing date.
• Pricing Structure: All-inclusive prices covering delivery to the specified location. Value Added Tax applies if the bidder is a registered VAT vendor.
• Product Condition: Only new, unused products are accepted. Items must have a minimum remaining validity period of six months upon delivery.

Technical Requirements

Bidders must ensure the supplied goods meet strict clinical and safety specifications:

• Brand and Specifications: The product must be the Cystofix brand, size 16.
• Safety Composition: Kits must be latex-free and free from DEHP.
• Reusability: The kit must be designed for reuse.
• Sterility: Products must be sterile.
• Clinical Function: The kit is intended for percutaneous placement of a drainage tube directly into the bladder, bypassing the urethra.
• Regulatory Approval: Bidders must possess a valid licence issued by the SAHPRA authorizing the manufacture, wholesale, or distribution of medical devices.
• Samples: The institution may request samples from the highest-scoring bidders for objective evaluation and verification against specifications.

Skills and Compliance Requirements

Requirements focus on vendor registration, regulatory adherence, and administrative compliance:

• CSD Registration: Suppliers must be registered on the Central Suppliers Database with verified status.
• Tax Compliance: Submission of a SARS PIN is mandatory to validate tax clearance status.
• Licencing: A current SAHPRA licence is compulsory.
• Mandatory Documentation: Completion of all Standard Bidding Documents, including SBD 4 (Disclosure of Interest) and SBD 6.1 (Preference Points Claim Form).
• Preference Points: Full points are allocated to companies at least 51% owned by Black People. Proof via BBBEE certificate or sworn affidavit is required to claim these points.
• Conflict of Interest: Bidders must disclose any relationships with employees of the KZN Department of Health.
• Financial Standing: Prices must be firm, and cover-quoting by multiple entities is strictly prohibited.

Explanation of Unusual Terms

SAHPRA Licence

Authorisation from the South African Health Products Regulatory Authority. This licence confirms the supplier is legally permitted to trade medical devices in South Africa, ensuring products meet safety and quality standards.

DEHP

Di(2-ethylhexyl) phthalate. A chemical plasticizer sometimes used in PVC medical products. Exclusion is required due to potential health risks associated with leaching into bodily fluids.

Percutaneous

A medical term meaning "through the skin." In this context, it refers to inserting a catheter through the abdominal wall directly into the bladder.

CSD

Central Suppliers Database. The national government database for registering suppliers. Verification here confirms the entity exists and meets basic compliance criteria.

SBD Forms

Standard Bidding Documents. Mandatory forms in South African public procurement. SBD 4 relates to declaring conflicts of interest, while SBD 6.1 is used to claim preferential procurement points based on ownership goals.

Cover-quoting

An illegal practice where multiple companies bid for a single client to artificially influence pricing or manipulate outcomes. This is strictly prohibited and results in immediate disqualification.